TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Anticoagulant Reversal Drug Market – By Product
1.3.2 Anticoagulant Reversal Drug Market – By Distribution Channel
1.3.3 Europe Anticoagulant Reversal Drug Market – By Country
2. Europe Anticoagulant Reversal Drug Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Anticoagulant Reversal Drug Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Anticoagulant Reversal Drug Market- Europe PEST Analysis
4.3 Expert Opinion
5. Europe Anticoagulant Reversal Drug Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rise in Prevalence of Atrial Fibrillation (AFib)
5.1.2 Increase in Prevalence of Stroke
5.2 Market Restraints
5.2.1 High Cost of Anticoagulant Reversal Drugs
5.3 Market Opportunities
5.3.1 Increasing Research Activities on Anticoagulant Reversal Drugs
5.4 Future Trends
5.4.1 Development and Launch of Innovative Products
5.5 Impact Analysis
6. Anticoagulant Reversal Drug Market – Europe Analysis
6.1 Europe Anticoagulant Reversal Drug Market Revenue Forecasts and Analysis
7. Europe Anticoagulant Reversal Drug Market Analysis and Forecasts To 2027 – By Product
7.1 Overview
7.2 Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
7.3 Prothrombin Complex Concentrates
7.3.1 Overview
7.3.2 Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.4 Vitamin K
7.4.1 Overview
7.4.2 Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.5 Protamine
7.5.1 Overview
7.5.2 Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.6 Tranexamic Acid
7.6.1 Overview
7.6.2 Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.7 Idarucizumab
7.7.1 Overview
7.7.2 Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
7.8 Andexxa
7.8.1 Overview
7.8.2 Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8. Europe Anticoagulant Reversal Drug Market Analysis and Forecasts to 2027– By Distribution Channel
8.1 Overview
8.2 Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
8.3 Hospital Pharmacies
8.3.1 Overview
8.3.2 Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8.4 Retail Pharmacies
8.4.1 Overview
8.4.2 Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
9. Anticoagulant Reversal Drug Market Revenue and Forecasts to 2027 – Geographical Analysis
9.1 Europe: Anticoagulant Reversal Drugs Market
9.1.1 Overview
9.1.2 Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
9.1.3 Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.1 Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.3.2 Germany: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.3.3 Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.1.4 France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.1 France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.4.2 France: Anticoagulant Reversal Drugs Market, by Product– Revenue and Forecast to 2027 (USD Million)
9.1.4.3 France: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.1.5 UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.1 UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.5.2 UK: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.5.3 UK: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.1.6 Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.1 Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.6.2 Italy: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.6.3 Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.1.7 Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.1 Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.7.2 Spain: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.7.3 Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
9.1.8 Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.1 Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
9.1.8.2 Rest of Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
9.1.8.3 Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
10. Impact Of COVID-19 Pandemic on Europe Anticoagulant Reversal Drug Market
10.1 Europe: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.2.2 Organic Developments Done By Companies
11.3 Inorganic Developments
11.3.1 Overview
11.3.2 Inorganic Developments Done By Companies
Source: The Insight Partners Analysis, Website, Press Releases and Others
12. COMPANY PROFILES
12.1 Boehringer Ingelheim International GmbH
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Pfizer Inc.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Octapharma AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 AMAG PHARMACEUTICALS, INC.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Fresenius Kabi AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 CSL Limited
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Grifols, S.A.
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. Germany: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 2. Germany: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 3. France: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 4. France: Anticoagulant Reversal Drugs Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 5. UK: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 6. UK: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 7. Italy: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 8. Italy: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 9. Spain: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 10. Spain: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 11. Rest of Europe: Anticoagulant Reversal Drugs Market, by Product – Revenue and Forecast to 2027 (USD Million)
Table 12. Rest of Europe: Anticoagulant Reversal Drugs Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)
Table 13. Glossary of Terms, Anticoagulant Reversal Drug Market
LIST OF FIGURES
Figure 1. Anticoagulant Reversal Drug Market Segmentation
Figure 2. Europe Anticoagulant Reversal Drug Market Overview
Figure 3. Prothrombin Complex Concentrates Segment Held Largest Share of Product in Anticoagulant Reversal Drug Market
Figure 4. Hospital Pharmacies Segment Held Largest Share of Distribution Channel in Anticoagulant Reversal Drug Market
Figure 5. Germany is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Anticoagulant Reversal Drug Market - Europe PEST Analysis
Figure 7. Anticoagulant Reversal Drug Market Impact Analysis of Driver and Restraints
Figure 8. Europe Anticoagulant Reversal Drug Market – Revenue Forecasts and Analysis – 2019- 2027
Figure 1. Anticoagulant Reversal Drugs Market Share, by Product, 2019 and 2027 (%)
Figure 2. Prothrombin Complex Concentrates: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 3. Vitamin K: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 4. Protamine: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 5. Tranexamic Acid: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 6. Idarucizumab: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 7. Andexxa: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 8. Anticoagulant Reversal Drugs Market Share, by Distribution Channel, 2019 and 2027 (%)
Figure 9. Hospital Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 10. Retail Pharmacies: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 11. Others: Anticoagulant Reversal Drugs Market– Revenue and Forecast to 2027 (USD Million)
Figure 12. Europe: Anticoagulant Reversal Drugs Market, by Key Country – Revenue (2019) (USD Million)
Figure 13. Europe: Anticoagulant Reversal Drugs Market, by Country, 2019 & 2027 (%)
Figure 14. Germany: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 15. France: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 16. UK: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 17. Italy: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 18. Spain: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 19. Rest of Europe: Anticoagulant Reversal Drugs Market – Revenue and Forecast to 2027 (USD Million)
Figure 20. Impact of COVID-19 Pandemic in European Country Markets
Figure 21. Growth Strategies Done by the Companies in the Market, (%)
